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Abstract 
Many reports have shown promising beneficial effects of long-chain polyunsaturated fatty acids 
(L-PUFAs) of the omega 3 series in several brain diseases. In the present study, we tested the 
hypothesis that a omega 3 fatty acids supplement reduced pro-inflammatory functions in vitro 
and in vivo. 
We demonstrated that a supplement rich in PUFAs (SRP) increased cell viability in dose-
dependent manner suggesting its protective role against LPS-induced cell death in BV2 
microglial cell line. In the same cultures, the supplement rich in PUFAs reduced the reactive 
oxygen species (ROS) and nitric oxide (NO) production. A most prominent target for ROS 
management is the family of peroxisome proliferator-activated receptors (PPARs). The co-
treatment with SRP and LPS increased significantly the nuclear immunoreactivity of PPAR-
γ when compared the LPS treatment alone. Moreover the chronic administration of the SRP in 
rats, increased the immunoreactivity of the PPAR-γ1 protein confirming its potential 
neuroprotective effect. 
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Introduction 
Clinical and experimental studies document promising beneficial effects of long-chain 
polyunsatured fatty acids (L-PUFAs) of the omega 3 series in a number of systemic pathologies, 
from diabetes to cardiovascular diseases, as well as in several brain diseases (Calder, 2014). The 
omega 3 L-PUFAs, including eicosapentaenoic acid (EPA; 20:5) and docosahexaenoic acid (DHA; 
22:6), derive from α-linolenic acid (ALA; 18:3) via desaturation and elongation. ALA must be 
obtained from the diet, longer-chain omega 3 can be formed in man but biological conversion in 
slow and inefficient making diet an important source for these fatty acids as well. Both omega 3  
and omega 6 L-PUFA are integral components of all cell membranes as part of the phospholipid 
bilayer. Within the phospholipid bilayer omega 3 L-PUFA  and omega  6 L-PUFA can be 
interchanged, where incorporation into the membrane depends largely on PUFA availability both 
from diet and from chemical synthesis. Membrane composition, however, affects membrane 
function: omega 3 L-PUFAs increase membrane fluidity and permeability and are considered 
important in cell signaling and signal transduction. 
DHA is the best represented  omega 3 L-PUFA in the nervous system, where it contributes more 
than 30% to the total phospholipid amount of neuronal and retinal membranes (Niemoller & Bazan, 
2010). DHA is not merely a structural membrane component but also a modulator of crucial 
neurochemical processes, gene expression, synaptic plasticity, memory formation and intracellular 
calcium concentration (Sergeeva, Strokin & Reiser, 2005; Crawford, 2006; McNamara, Carlson, 
2006; Calder, 2009; Grintal et al., 2009). In addition, similarly to what was observed in a number of 
inflammatory based systemic disorders, DHA and its peroxidated (cyclopentenone neuroprostanes) 
or enzymatically generated (neuroprotectins and resolvins) derivatives display potent 
antiinflammatory functions in psychiatric disorders as well as in acute and chronic 
neurodegenerative conditions (Bazan, 2006; Musiek et al., 2008; Calder, 2009; Ebert et al., 2009; 
Groeger et al., 2010; Palacios-Pelaez, Lukiw, & Bazan, 2010; Belayev et al., 2011). 
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DHA exerts its effect also trough the interaction with the peroxisome proliferator-activated receptor 
(PPAR). During different neuropathological conditions the natural PPAR ligands are produced in 
high amounts. Besides activation of PPARs, these ligands have a variety of direct effects on neural 
cells, such as regulation of inflammation, calcium homeostasis and mitochondrial functions. Thus, 
PPARs and their ligands have well proven neuroprotective effects, and there are a number of reports 
concerning the PPAR involvement in regulation of ROS production. PPAR-γ exists in two isoforms 
with no functional differences (PPAR-γ1 and γ2), and is highly expressed in adipose tissue, where it 
plays a central role in the regulation of adipogenesis (Willson, Lambert & Kliewer, 2001). In 
addition, PPAR-γ is found in cells of the immune system, including lymphocytes and macrophages. 
In peripheral monocytes, PPAR-γ expression is induced during the process of extravasation from 
blood vessels into the tissues, and in the course of activation by pro-inflammatory stimuli. PPAR-γ 
has been shown to be important for the differentiation of monocytes into macrophages and to act as 
a negative regulator of macrophage activation (Ricote et al., 1998a; Ricote, Li, Willsons, Kelly & 
Glass, 1998b; Tontonoz, Nagy, Alvarez, Thomazy & Evans, 1998 Daynes & Jones, 2002). As for 
macrophages of peripheral tissues, PPAR-γ regulates the activation of microglial cells, the main 
macrophage population found in brain parenchyma, suggesting that PPAR-γ natural and synthetic 
agonists may control brain inflammation and that they could be exploited for the treatment of 
human brain diseases such as multiple sclerosis, Alzheimer’s disease and Parkinson’s disease. 
The aim of the present study was to evaluate the potential neuroprotective effects of a supplement 
rich in PUFAs (SRP) in vitro in parallel to a modulation of PPAR-γ in rat cerebral cortex. 
 
Materials and methods 
Cell cultures and treatments 
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The experiments were conducted on BV2 murine microglial cell line (ATCC, Teddington, UK). 
Cells were cultured in a humidified incubator at 37°C with 5% CO2 in Dulbecco's modified Eagle's 
medium (DMEM; Sigma Aldrich SRL, Milan, Italy) containing 10% heat-inactivated fetal bovine 
serum FBS, 2 mM L-glutamine (all from Invitrogen SRL, San Giuliano Milanese, Italy) with 100 
units/mL penicillin and 100 µg/mL streptomycin, 1 mL non-essential amino acids, 1 mM sodium 
pyruvate (all from Sigma Aldrich SRL, Milan, Italy). The cultures were treated with a supplement 
rich in PUFAs (SRP) available on the market. The supplement rich in PUFAs, named Triolip® 
1000 and provided by Sofar (Milan, Italy), derived from fish contains particularly high 
concentrations of EPA and DHA, respectively 40 and 20%. The SRP is composed of 16.52% 
protein, 0% carbohydrates, 82.65 fats (7.44% saturated, 9.918% monounsaturated, 65.293% 
polyunsaturated: 33.06% EPA, 16.53% DHA), 0.826% vitamin E. The fatty acids composition of 
SRP was verified by GC-MS analysis (Avallone et al., 2009). The use of advanced technology of 
extraction processes (multiple molecular distillation), which characterizes this formulation, ensures 
very low levels of pollutants such as dioxins, mercury and heavy metals normally present marine 
habitat. Moreover, the addition of vitamin E allows absolute protection of the active principles from 
peroxidative agents. In the supplement rich in PUFAs, EPA and DHA are present in the form of 
triglycerides. SRP stock solution was dissolved in dimethyl sulfoxide (DMSO Sigma Aldrich SRL, 
Milan, Italy) and then diluted at final concentrations ranging from 0.5 µg/mL (corresponding to 0,5 
µM of EPA and 0,25 µM of DHA) to 40 µg/mL (corresponding to 40 µM of EPA and 20 µM of 
DHA) in DMEM. The final concentration of DMSO in the medium was less than 0.05% (vol/vol). 
Animals and diets 
Six-week-old male Sprague-Dawley rats (200-250 g) (Harlan Italy, Udine, Italy) were used 
throughout the experiment in a controlled environment (air-conditioned room at 22±1 ◦C and 60% 
humidity) maintained under a 12 h light/dark cycle. Rats had free access to water and food, a 
standard pellet containing 188 g kg−1 crude proteins, 60 g kg−1 crude fats, 38 g kg−1 fibre and 500 
g kg−1 carbohydrates. The animals were randomly assigned to one of two groups (olive oil 
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supplemented named olive oil fed group and supplement rich in PUFAs named SRP group) and 
treated for 30 days by oral gavage as follows: the olive oil fed group (n = 10) and the SRP group (n 
= 10) received respectively 2 g of extra virgin olive oil and 2 g/rat/day of the supplement rich in 
PUFAs (Rustichelli et al,  2012). The use of extra virgin olive oil in the olive oil fed group is 
necessary to match the caloric content due to fatty acids supplementation and to remove the weight 
gain influence. Animals were sacrificed 24 h after the last treatment. The cerebral cortices were 
collected, washed free from blood in ice-cold normal saline solution, dried with blotting paper and 
then stored at −80 °C until analysis. All procedures were performed in accordance with the 
guidelines of the National (DL no. 116/1992) and European legislation (EEC no. 86/609) and 
guidelines of the National Institutes of Health on the use and care of laboratory animals. 
Cell viability test 
Cytotoxicity assays were performed with the CellTiter-96® AQueousMTS Proliferation Assay 
(Promega, Milan, Italy) in 96 well plates. BV2 microglial cells were seeded at a density of 10,000 
cells per well. Cytotoxicity was measured by adding 20 µL MTS (3-[4,5-dimethylthiazol-2-yl]-5-[3-
carboxymethoxyphenyl]-2-[4-sulfophenyl]-2H-tetrazolium, inner salt] 24 h after treatments 
according to the manufacturer's protocol. Cells were treated with 0.05, 0.5, 5, 10, 20 µg/mL of the 
supplement rich in PUFAs in presence or absence of lipopolysaccharide (LPS) (Sigma, Milan, Italy) 
at the concentration of 1 µg/mL. The microplates were incubated at 37 °C for up to 2 hours and the 
absorbance was detected at 492 nm using a spectrophotometer (Labsystem Multiscan® MCC/340, 
Finland). 
ROS assay 
To examined the effect of the supplement rich in PUFAs on reactive oxygen species (ROS) 
production in LPS-stimulated BV2 microglial cell lines, the fluorogenic probes CellROX® Green 
Flow Cytometry Assay Kit (Life Technologies, Milan, Italy), designed to reliably measure ROS in 
live cells, have been used. The fluorescence resulting from CellROX® Oxidative Stress Reagents 
was measured using a microplate fluorometer (Fluoroskan Ascent FL, Biorad, Milan, Italy). 
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Briefly, BV2 microglial cells were seeded at concentration of 15000 cells/well and stimulated for 
6 h with LPS (1 µg/mL) in the absence or presence of different concentrations of SRP. 
Successively, 10 µL of "CellROX Green" solution were added in each well 30 minutes before the 
end of treatment at the concentration of 5 µM and the fluorescence were measure using "fluorskan 
Ascent FL". 
NO assay 
Griess reagent kit (Molecular Probe-Life Technologies, Milan, Italy) was used to measure the 
production of nitric oxide (NO) present in the supernatant of BV2 microglial cells treated with LPS 
(1 µg/mL) for 24 hours (Ajmone-Cat, 2012), with increasing concentrations of SRP (0.5-10 µg/mL) 
according to the manufacturer’s instructions. Briefly, 10000 cells were seeded and incubated for the 
different compounds. After 24 h 85 µL of buffer assay was added to each sample, 5 µL of nitric 
reductase, 5 µL of enzyme cofactor were successively added to each well and incubated for 1 hour 
at room temperature. 5 µL of promoter was added to each well successively incubated for 10 
minutes. The samples were mixed with an equal volume (50 µL) of freshly prepared Griess reagent, 
and the absorbance was measured at 540 nm using a spectrophotometer (Labsystem Multiscan® 
MCC/340, Finland). 
Immunoblotting 
To examine the expression of PPARγ protein in the BV2 microglial cells and cerebral cortex of rats, 
standard western blot analysis was performed. Cells treated with LPS (1 µg/mL), SRP (10 µg/mL), 
LPS in presence of the supplement rich in PUFAs (10 µg/mL) or not-treated cells were lysed in 
RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Na deoxycolate, 1% Triton X-100, 2 
mM PMSF) (Sigma, Milan, Italy). Nuclei extraction from BV2 microglial cells was performed 
using a density barrier system. Cells were scraped from 150 mm dishes into 3 mL Tris phosphate 
buffered saline (20 mM Tris-HCl, 0.5 M NaCl and 0.05 % Tween 20) (TBST) and centrifuged at 
36000g for 10 min. Cell pellets were resuspended in TBST and homogenized with potter. The 
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homogenate was adjusted to 25% (w/v) iodixanol (Sigma, Milan, Italy) and layer over a barrier of 
30% (w/v) iodixanol and then centrifuged at 10000g for 20 min. The obtained pellet was enriched 
in nuclei. The cerebral cortex was homogenized with RIPA and centrifuged at 12000g for 10 
minutes at 4 °C and the supernatants were collected. The proteins quantification was performed 
using Bradford colorimetric method Commassie (Pierce, Rockford, USA) according to the 
manufacturer’s protocol. Equal amount of proteins, ranging from 0.5 to 10 µg/µl, were separated 
through 12% SDS-PAGE mini gel and electrophoretically transferred onto nitrocellulose membrane 
all purchased from Invitrogen (Life Technology, Milan, Italy). The membrane was blocked in 
TBST containing 10% milk overnight at 4 °C at room temperature (RT) and incubated with primary 
antibody anti-PPARγ (1 : 500) at RT for 3 hours (Cayman Chemical Company, Ann Arbor, USA). 
Membrane was then washed 5 times in TBST for 10 min. each time, incubated for 1 h with HRP-
conjugated anti-rabbit secondary antibody (Santa Cruz, Dallas, USA), and visualized using 
chemiluminescence method (Amersham, GE Healthcare Europe GmbH, Milan, Italy). The 
membrane was successively stripped and incubated with a primary antibodies anti-β-actin (1:5000) 
or anti-lamin (1:1000) followed by incubation with HRP-conjugated anti-mouse secondary antibody 
respectively (Millipore, Darmstadt, Germany). The immune-complexes were visualized using 
chemiluminescent method, and analyzed using a BioRad GS 690 Imaging densitometer with 
molecular analysis software (Life science, Milan, Italy). 
Statistical Analysis 
The results are expressed as mean ± standard deviation (SD) of at least three independent 
experiments done in quadruplicate. Comparison of multiple means was performed using one-way 
ANOVA with the Tukey's and Dunnett's as post hoc test and t-test was performed to compare two 
groups, as indicated in the figures (Graph Pad Inc., La Jolla, USA). Mean values were considered 
significantly different when P < 0.05 as outlined in the text. 
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Results 
Supplement rich in PUFAs protects BV2 microglial cells LPS-mediated cytotoxicity 
To investigate the potential cytotoxic effect of the supplement rich in PUFAs, BV2 microglial cells 
were treated with different concentrations of SRP. As shown in Fig. 1A, no cytotoxic effects were 
observed following treatment of BV2 microglial cells with 0.5–20 µg/mL of SRP for 24 h. 
Concentration of 40 µg/mL produced cytotoxic effects and then it was excluded from further 
experiments. Furthermore, to determine whether treatment with SRP protects against the cell death 
induced by LPS, BV2 microglial cells were treated with different concentrations of SRP in presence 
or not of 1 µg/mL LPS. As shown in Fig. 1B, the co-treatment of SRP and LPS on BV2 cells 
increased significantly the conversion of MTS in formazan product compared to values obtained in 
LPS-stimulated cultures alone. Indeed, the treatment with SRP increased significantly BV2 cell 
viability compared to LPS-treated cells, restoring the values to those of the control. 
Supplement rich in PUFAs inhibits ROS and NO production in activated BV2 microglial cells 
To study the ability of the SRP to modulate the microglial activation, we examined the effects of 
this supplement at different concentrations on LPS-induced ROS and NO production in BV2 cell 
line. We exposed microglial cultures to increasing concentrations of SRP, in the absence or in the 
presence of LPS and measured the ROS production and the levels of nitrite, a stable end product of 
NO accumulated in the medium. Incubation with LPS for 6 h significantly increased the ROS 
production in BV2 cells, when compared to that in untreated cells. However, co-treatment with the 
SRP, significantly prevented the increase of ROS production in BV-2 cells in a dose dependent 
manner (Fig. 2). The SRP alone at the higher concentration tested did not alter ROS production in 
BV-2 cells (data not shown). Similarly, SRP treatment was able to modulate the LPS-related NO 
production in BV2 cells. The amount of nitrite was measured after 24 h of treatment with SRP in 
presence or not of LPS. In the absence of LPS, basal nitrite production was close to the detection 
limit of the assay and remained undetectable in the presence of SRP (data not shown). However, 
SRP significantly reduced, in a dose-dependent manner, the LPS-induced nitrite accumulation in 
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BV2 microglia cells as shown in Fig. 3. 
Effect of SRP on PPARγ nuclear translocation and PPARγ expression in activated BV2 microglia 
cells 
The activation of PPAR-γ nuclear receptors, through ligands agonist such as DHA (Yu et al., 1995; 
Kliewer et al., 1997), has been proposed as anti-inflammatory machinery in the central nervous 
system (Combs, Johnson, Karlo, Cannady & Landreth, 2000; Niemoller & Bazan, 2010). To verify 
the hypothesis that the SRP could induce PPAR-γ activation in BV2 microglia cells, we analyzed 
PPAR-γ protein expression and its nuclear translocation following exposure to 10 µg/mL of the 
SRP in presence or not of LPS. Western blot analysis showed that the treatment with SRP did not 
induce an increase of PPARγ protein in the total cell lysate of BV2 microglia cells. Indeed, the 
immunoreactivity of the treated cells did not change compared to control, suggesting that the 
expression of PPARγ is not affected by S P and/or LPS (Fig. 4 C, D). However, as shown in Fig. 
4A, an increase in immunoreactivity intensity was observed in nuclear subcellular fraction of 
cultures exposed to SRP for 90 min. compared with untreated cells, confirming the data by Ajmone-
Cat et al., 2012. Conversely, LPS was able to inhibit the PPARγ nuclear translocation resulted in 
immunoreactivity barely detectable (Fig. 4A). SRP treatment was able to counteract the LPS effect 
on the translocation of PPARγ. Indeed, the co-treatment with SRP and LPS increased significantly 
the nuclear immunoreactivity of PPAR-γ when compared the LPS treatment alone (Fig. 4B). 
However, immunoblotting analysis on BV2 total cell lysate did not show any difference between 
control and treated cells (data not shown). 
Supplement rich in PUFAs modulates PPARs protein expression in rat cerebral cortex 
In order to evaluate the effect of SRP on PPARγ protein expression in physiological condition, 
Sprague Dawley male rat were chronically treated with 2 g/rat/day of SRP and Western blot 
analysis was performed on crude tissue homogenates with specific antibodies. As shown in Fig. 5A, 
immunochemical results showed a significant modulation of PPARγ1 proteins expression in rat 
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cerebral cortex. Western blot analysis of PPARγ protein, revealed the presence of a 57 kDa and a 52 
kDa molecular mass level proteins corresponding to PPAR γ2 and PPAR γ1 respectively. As shown 
in Figure 5 while the intensity of PPAR γ2 immunosignal was not affected by the SRP treatment, 
the PPARγ1 protein significantly increased its immunoreactivity in treated samples compared to the 
not-treated ones (Fig. 5B). 
 
Discussion 
PUFAs are essential for normal human growth; however, only minor quantities of the beneficial 
omega 3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are synthesized by 
human metabolism. A small amount of EPA and DHA (less than 5%) can be converted through 
enzymatic reactions by ALA in the human body (Brenna, 2002). So the use of nutraceutical and 
functional foods containing omega 3 PUFAs has become a topic of great interest for the health of 
the world population, due to their reported and accepted beneficial effects. 
The present study tested the hypothesis that a supplement rich in PUFAs containing high 
concentrations of EPA and DHA, reduced LPS-induced microglial pro-inflammatory functions. 
In spite of its defensive nature, microglial activation may contribute to neuronal functional 
impairment when inappropriately triggered or deployed to excess. It is now clear that the process of 
microglia activation is tightly controlled by soluble factors and cell-to-cell interactions, and that the 
failure of such control may lead to severe neuronal impairment (Polazzi & Contestabile, 2002; De 
Simone, Ajmone-Cat & Minghetti, 2004). In this context omega 3 PUFAs EPA and DHA might 
exert their potential beneficial effects by protecting and/or regulating the microglia functions. 
Although in the supplement rich in PUFAs used in these experiments it’s impossible to discriminate 
the effects of DHA and those of EPA as DHA, our results demonstrated that SRP increased BV2 
cell viability in a dose-dependent manner suggesting its protective role against LPS-induced cell 
death in BV2 microglial cell line. However, the role of microglia appears particularly important in 
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chronic degenerative diseases, in which activated microglia sustains a local inflammatory response 
(Perry, Bolton, Anthony & Betmouni, 1998) trough oxidative stress activation and cytokines release 
(Wang, Wen, Huang, Chen & Ku, 2006). Thus, the identification of compounds and molecular 
mechanisms that prevent glial reaction, in particular microglial activation, is crucial for the 
development of therapeutic agents for inflammatory brain diseases. 
Oxidative stress is responsible for redox regulation involving not only ROS but also NO production. 
Both ROS and reactive nitrogen species can oxidize and damage macromolecules, such as DNA, 
proteins, and lipids, culminating in neurodegeneration in the central nervous system (Wang, Wen, 
Huang, Chen & Ku, 2006). Noteworthy was the evidence that, in the BV2 microglial cell line, a 
supplement rich in PUFAs strongly reduced the ROS and NO production consistently with reports 
on peripheral macrophages and microglial cell lines (Khair-El-Din et al., 1996; De Smedt-Peyrusse 
et al., 2008; Calder, 2009). A most prominent target for ROS management is the peroxisome 
proliferator-activated receptors family (PPARs). In our study the co-treatment with a supplement 
rich in PUFAs and LPS increased significantly the nuclear immunoreactivity of PPAR-γ when 
compared the LPS treatment alone but not in the total cell lysate, suggesting that SRP might act as 
activator of nuclear PPAR-γ rather then a modulator of protein expression in BV2 cell line.  As a 
further contributing mechanism, our data suggest that a supplement rich in PUFAs induces the 
nuclear translocation of the nuclear receptor PPAR-γ, a potent modulator of microglial activation. 
PPAR-γ belongs to a broad family of agonist-dependent transcription factors that modulate the 
expression of several genes involved in metabolic, developmental, and immune processes 
(Bernardo & Minghetti, 2008). In particular, in LPS or IFN-γ-stimulated microglia, PPAR-γ 
activation decreases the expression of proinflammatory mediators, and PPAR-γ agonists have been 
proposed for treating inflammatory brain diseases (Bernardo & Minghetti, 2006). The inhibitory 
activity of the supplement rich in PUFAs on observed NO production could be interpreted as an 
effect of PPARγ activation. Our observations are in line with the current literature that lists PPAR-γ 
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among the molecular targets of DHA and other PUFAs in adipocytes, dendritic cells, and microglia 
(Yu et al., 1995; Kliewer et al., 1997; Combs, Johnson, Karlo, Cannady & Landreth, 2000; 
Niemoller & Bazan, 2010). It is well known, however, that PPAR agonists may have also PPAR-
independent effect. We cannot rule out the contribution to the observed effects of biologically 
active DHA derivatives, e.g., resolvins and neuroprotectins, enzymatic oxygenated products 
isolated and characterized as potent proresolving mediators. 
Interesting was the results obtained in animals fed with the a supplement rich in PUFAs. Indeed the 
chronic administration of the SRP increased the immunoreactivity of the PPAR γ1 protein, whereas 
the PPAR γ2 protein expression was unaffected. This result suggests that omega 3 PUFA might act 
in a preventive fashion in vivo exerting a potential neuroprotective effect. Indeed, the chronic use of 
the SRP through PPAR γ1 activation has a potential anti-inflammatory effect. It was demonstrated, 
in fact, that PPARs may reduce ROS levels via induction of ROS-degrading pathways, such as 
catalase, superoxide dismutase, glutathione peroxidase, cytochrome c oxidase, gamma-
glutamylcysteine ligase and glutathione. Another way for PPAR-dependent downregulation of ROS 
levels is the ability to reduce levels of ROS-producing pathways, such as NO synthase, 
myeloperoxidase, NAPH oxidase, cofactor tetrahydrobiopterin and argininosuccinate lyase. The 
PPAR receptors may induce ROS levels via upregulation of peroxisomal oxidation and, especially, 
by induction of Acyl-CoA oxidases (Aleshin & Reiser, 2013). Thus, the PPAR-dependent positive 
and negative ROS regulation is important to maintain balanced ROS levels.  
Our results showed a different pattern of PPARγ protein expression between in vivo and in vitro 
model.  This discrepancy could be due to the different substrate used. Indeed in the cerebral tissues 
there is a wide range of cell population, which in turn might express different isoforms of the 
mentioned protein, compared to the microglia alone. Another speculation could be that the BV2 
mainly express PPAR-γ2, also in vivo their expression was not affected by SRP, and that after 
activation with the SRP the receptors translocate to the nucleus exerting neuroprotective functions. 
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Conclusion 
Finally, our data confirm that the activation of PPAR by a supplement rich in PUFAs will be a 
powerful therapeutic tool for normalization of ROS levels in a wide range of neuropathological 
diseases. In the supplement rich in PUFAs used in this study, EPA and DHA are present in the form 
of triglycerides, micronutrients naturally recognized by the body, to guarantee high digestibility and 
absorption by the intestinal mucosa. This allows to reduce the daily administration of the product, 
compared to the omega 3 in the form of ethyl esters. Oily fish intake amongst many populations is 
low and infrequent. An alternative source of ω 3 PUFAs which can be taken regularly is 
supplements such as fish oil. Most fish oils contain about 30% of EPA and DHA. Thus, a single one 
gram capsule of fish oil can provide about 300 mg EPA plus DHA. The supplement rich in PUFAs 
used in the present study is a highly concentrated, pharmaceutical preparation of omega 3 PUFAs 
containing about 60% EPA plus DHA. Our results support the notion that dietary fish oil 
supplementation may enhance resistance to free radical attack and also that ω 3 fatty acids may be 
effective dietary supplement in the management of various diseases in which oxidant/antioxidant 
balance is disturbed as in neuroinflammation. 
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Cell viability of BV2 microglial cell line after exposure to different concentrations of supplement rich in PUFAs 
(SRP) and LPS. (A) Effects of 24 h exposure to different concentrations of SRP on BV2 microglial cell line 
monitored by the MTS assay. Only the highest concentration of SRP decreased significantly the BV2 cell 
viability compared to not-treated cells: ***P < 0.001 vs Ctrl using one-way ANOVA with Dunnett’s as post 
test. (B) Effects of the supplement rich in PUFAs (SRP) on LPS-induced cytotoxicity on BV2 microglial cell 
line (++P< 0.01 vs Ctrl, using one-way ANOVA with Tukey’s as post test). SRP significantly decreased the 
BV2-cytotoxicyty elicited by LPS at all the concentrations tested. Values represent means ± SD from three 
different experiments (n=6). *P< 0.05, **P< 0.01, ***P< 0.001 vs LPS using one-way ANOVA with Tukey’s 
as post test.  
196x353mm (300 x 300 DPI)  
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ROS formation in LPS-activated BV2 microglial cell line as measured by Cell-ROX assay after 24 h of 
exposure in presence or not to different concentrations of supplement rich in PUFAs (SRP). Results are 
expressed as median fluorescence intensity (MFI). LPS treatment significantly increased the MFI compared 
to not-treated cells (+++P< 0.001 vs Ctrl, using one-way ANOVA with Tukey’s as post test). Co-treatment 
of BV2 microglial cells with LPS and different concentrations of SRP significantly reduced the level of ROS in 
LPS-activated BV2 cell line. Data shown are means ± SD of three independent experiments (n=6). **P< 
0.01, and ***P< 0.001 vs LPS using one-way ANOVA with Tukey’s as post test.  
80x64mm (600 x 600 DPI)  
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Effect of supplement rich in PUFAs (SRP) on LPS-activated BV2 microglial cell line nitrite levels as measured 
by the absorbance at λ 540 nm. BV2 microglial cell line treatment with LPS of for 24 h resulted in a 
significant increase of nitrite levels compared to the not-treated cells referred as control (+++P< 0.001 vs 
Ctrl, using one-way ANOVA with Tukey’s as post test). Co-administration of LPS and SRP at different 
concentrations on BV2 microglial cells significantly reduced LPS-activated BV2 nitrite levels: *P< 
0.05,***P< 0.001 vs LPS using one-way ANOVA with Tukey’s as post test. Data shown are means ± SD of 
three independent experiments (n=5).  
72x50mm (300 x 300 DPI)  
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Nuclear PPARγ protein expression of BV2 microglial cell line following a 90 min. exposure to supplement rich 
in PUFas (SRP) (10 µg/mL), LPS (1 µg/mL), LPS (1 µg/mL) + SRP (10 µg/ml) or not-treated cells. (A) 
Representative western blots of five independent experiments. (B) Densitometric analysis of nuclear protein 
levels of PPARγ after incubation with 10 µg/mL of SRP for 90 min. in presence or not of LPS 1 µg/mL. The 
values were normalized to the protein loading control, lamin and the results are means ± SD of five 
independent experiments. *P< 0.05 and **P< 0.01 vs not-treated cells (Ctrl); ++P< 0.01 vs LPS using one-
way ANOVA with Tukey’s as post test.  
(C) Representative western blots analyses and densitometric analysis (D) of PPARγ protein levels of BV2 
microglial cell lysate after incubation with LPS 1 µg/mL, with 10 µg/mL of SRP in presence or not of LPS (1 
µg/mL) for 24 h and in no treated cells (Ctrl). The results are representative of four independent 
experiments.  
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Representative western blots analyses of PPARγ1/2 protein levels in cerebral cortex of rats fed for 1 months 
with 2 g/rat/day of supplement rich in PUFAs (SRP) or fed with 2g/rat/day of olive oil fed group (OOG). (A) 
The results are representative of four independent experiments. (B) Densitometric analyses of cerebral 
protein levels of PPARγ1/2. The values were normalized to the protein loading control, β-actin and the 
results are means ± SD of five independent experiments. ***P< 0.01 vs olive oil fed group (OOG) using 
paired t-test.  
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Figure captions 
 
Figure 1. Cell viability of BV2 microglial cell line. 
Cell viability of BV2 microglial cell line after exposure to different concentrations of supplement 
rich in PUFAs (SRP) and LPS. (A) Effects of 24 h exposure to different concentrations of SRP on 
BV2 microglial cell line monitored by the MTS assay. Only the highest concentration of SRP 
decreased significantly the BV2 cell viability compared to not-treated cells: 
***
P < 0.001 vs Ctrl 
using one-way ANOVA with Dunnett’s as post test. (B) Effects of the supplement rich in PUFAs 
(SRP) on LPS-induced cytotoxicity on BV2 microglial cell line (
++
P< 0.01 vs Ctrl, using one-way 
ANOVA with Tukey’s as post test). SRP significantly decreased the BV2-cytotoxicyty elicited by 
LPS at all the concentrations tested. Values represent means ± SD from three different experiments 
(n=6). 
*
P< 0.05, 
**
P< 0.01, 
***
P< 0.001 vs LPS using one-way ANOVA with Tukey’s as post test. 
Figure 2. ROS formation in LPS-activated BV2 microglial cell line. 
ROS formation in LPS-activated BV2 microglial cell line as measured by Cell-ROX assay after 24 
h of exposure in presence or not to different concentrations of supplement rich in PUFAs (SRP). 
Results are expressed as median fluorescence intensity (MFI). LPS treatment significantly increased 
the MFI compared to not-treated cells (
+++
P< 0.001 vs Ctrl, using one-way ANOVA with Tukey’s 
as post test). Co-treatment of BV2 microglial cells with LPS and different concentrations of SRP 
significantly reduced the level of ROS in LPS-activated BV2 cell line. Data shown are means ± SD 
of three independent experiments (n=6). 
**
P< 0.01, and 
***
P< 0.001 vs LPS using one-way ANOVA 
with Tukey’s as post test. 
Figure 3. NO production in LPS-activated BV2 microglial cell line. 
Effect of supplement rich in PUFAs (SRP) on LPS-activated BV2 microglial cell line nitrite levels 
as measured by the absorbance at λ 540 nm. BV2 microglial cell line treatment with LPS of for 24 h 
resulted in a significant increase of nitrite levels compared to the not-treated cells referred as control 
(
+++
P< 0.001 vs Ctrl, using one-way ANOVA with Tukey’s as post test). Co-administration of LPS 
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and SRP at different concentrations on BV2 microglial cells significantly reduced LPS-activated 
BV2 nitrite levels: 
*
P< 0.05,
***
P< 0.001 vs LPS using one-way ANOVA with Tukey’s as post test. 
Data shown are means ± SD of three independent experiments (n=5). 
Figure 4. Protein expression of BV2 microglial cell line. 
Nuclear PPARγ protein expression of BV2 microglial cell line following a 90 min. exposure to 
supplement rich in PUFas (SRP) (10 µg/mL), LPS (1 µg/mL), LPS (1 µg/mL) + SRP (10 µg/ml) or 
not-treated cells. (A) Representative western blots of five independent experiments. (B) 
Densitometric analysis of nuclear protein levels of PPARγ after incubation with 10 µg/mL of SRP 
for 90 min. in presence or not of LPS 1 µg/mL. The values were normalized to the protein loading 
control, lamin and the results are means ± SD of five independent experiments. 
*
P< 0.05 and 
**
P< 
0.01 vs not-treated cells (Ctrl); 
++
P< 0.01 vs LPS using one-way ANOVA with Tukey’s as post test. 
(C) Representative western blots analyses and densitometric analysis (D) of PPARγ protein levels 
of BV2 microglial cell lysate after incubation with LPS 1 µg/mL, with 10 µg/mL of SRP in 
presence or not of LPS (1 µg/mL) for 24 h and in no treated cells (Ctrl). The results are 
representative of four independent experiments. 
Figure 5. Western blots of PPARγ protein levels in cerebral cortex of rats. 
Representative western blots analyses of PPARγ1/2 protein levels in cerebral cortex of rats fed for 1 
months with 2 g/rat/day of supplement rich in PUFAs (SRP) or fed with 2g/rat/day of olive oil fed 
group (OOG). (A) The results are representative of four independent experiments. (B) 
Densitometric analyses of cerebral protein levels of PPARγ1/2. The values were normalized to the 
protein loading control, β-actin and the results are means ± SD of five independent experiments. 
***
P< 0.01 vs olive oil fed group (OOG) using paired t-test. 
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